Tumor necrosis factor-α and interleukin-10 gene expression in peripheral blood mononuclear cells after cardiac surgery

Critical Care Medicine

Volumn 34, Issue 8, 2006, Pages 2134-2139

  Duggan, Edel ^a   Caraher, Emma ^b   Gately, Kathy ^b   O'Dwyer, Michael ^a   McGovern, Eilis ^a   Kelleher, Dermot ^b   McManus, Ross ^b   Ryan, Thomas ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b Dublin Molecular Medicine Centre   (Ireland)

Author keywords

Cardiac surgery; Cytokine; Gene; Heart; Messenger ribonucleic acid; Outcome; Postoperative complications; Surgery

Indexed keywords

INTERLEUKIN 10; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; CARDIOTONIC AGENT; LACTIC ACID;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE EXPRESSION; GENOTYPE; HAPLOTYPE; HEART SURGERY; HUMAN; HYPERLACTATEMIA; INOTROPISM; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNIVERSITY HOSPITAL; BLOOD; CASE CONTROL STUDY; GENETICS; METABOLISM; MONONUCLEAR CELL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; TIME;

ADULT; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HAPLOTYPES; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-10; LACTIC ACID; LEUKOCYTES, MONONUCLEAR; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748119276     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000227647.77356.AB     Document Type: Article

References (33)

1. Cremer J, Martin M, Redl H, et al: The systemic inflammatory response after cardiac operations. Ann Thorac Surg 1996; 61:1714-1720
2. Goldie A, Fearon KCH, Ross JA, et al: Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. JAMA 1995; 274:172-177
3. Hall RI, Smith MS, Rocker G: The Systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic and pharmacologic considerations. Anesth Analg 1997; 85:766-782
4. Roth-Isigkeit A, Hasselbach L, Ocklitz E, et al: Inter-individual differences in cytokine release in patients undergoing cardiac surgery with cardiopulmonary bypass. Clin Exp Immunol 2001; 125:80-88
5. Wei M, Kuukasjarvi P, Laurikka J, et al: Inflammatory cytokines and soluble receptors after coronary artery bypass grafting. Cytokine 2001; 15:223-228
6. McBride WT, Armstrong MA, Crockard AD, et al: Cytokine balance and immunosuppressive changes at cardiac surgery: Contrasting response between patients and isolated CPB circuits. Br J Anaesth 1995; 75:724-733
7. Munoz C, Misset B, Fitting C, et al: Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur J Immunol 1991; 21:2177-2184
8. Misoph M, Babin-Ebell J: Interindividual variations in cytokine levels following cardiopulmonary bypass. Heart Vessels 1997; 12:119-127
9. Butler J, Parker D, Pillai R, et al: Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 1993; 105:25-30
10. Brix-Christensen V, Vestergaard C, Chew M, et al: Plasma cytokines do not reflect expression of pro- and anti-inflammatory cytokine mRNA at organ level after cardiopulmonary bypass in neonatal pigs. Acta Anaesthesiol Scand 2003; 47:525-531
11. Van Dissel JT, Van Langefelde P, Westendorp RG, et al: Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998; 351:950-953
12. Turner DM, Williams DM, Sankaran D, et al: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24:1-8
13. Heesen M, Kunz D, Bachmann-Mennenga B, et al: Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: Association with TNF-alpha response of granulocytes to endotoxin stimulation. Crit Care Med 2003; 31:211-214
14. Tang GJ, Huang SL, Yien HW, et al: Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 2000; 28:2733-2736
15. Mira JP, Cariou A, Grall F, et al: Association of TNF-2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality. JAMA 1999; 282:561-568
16. Ryan T, Balding J, McGovern EM, et al: Lactic acidosis after cardiac surgery is associated with polymorphisms in tumor necrosis factor and interleukin 10 genes. Ann Thorac Surg 2002; 73:1905-1909
17. Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-989
18. Stephens M, Donnelly P: A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73:1162-1169
19. Beutler B, Cerami A: The biology of cachectin/TNF: A primary mediator of the host response. Annu Rev Immunol 1989; 7:625-655
20. Chew MS, Brandslund I, Brix-Christensen V, et al: Tissue injury and the inflammatory response to pediatric cardiac surgery with cardiopulmonary bypass: A descriptive study. Anesthesiology 2001; 94:745-753
21. Fisher CJ Jr, Agosti JM, Opal SM, et al: Treatment of septic shock with the tumor necrosis factor receptor Fc fusion protein: The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 1996; 334:1697-1702
22. de Waal Malefyt R, Abrams J, Bennett B, et al: Interleukin 10 (IL 10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL 10 produced by monocytes. J Exp Med 1991; 174:1209-1220
23. Schneider CP, Schwacha MG, Chaudry IH: The role of interleukin-10 in the regulation of the systemic inflammatory response following trauma-hemorrhage. Biochim Biophys Acta 2004; 1689:22-32
24. van der Poll T, Jansen PM, Montegut WJ, et al: Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J Immunol 1997; 158:1971-1975
25. Shames BD, Selzman CH, Meldrum DR, et al: Interleukin-10 stabilizes inhibitory kappaB-alpha in human monocytes. Shock 1998; 10:389-394
26. Oberholzer A, Oberholzer C, Moldawer LL: Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 2002; 30(1 Suppl):S58-S63
27. van der Poll T, Jansen J, Levi M, et al: Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med 1994; 180:1985-1988
28. Scumpia PO, Moldawer LL: Biology of interleukin-10 and its regulatory role in sepsis syndrome. Crit Care Med 2005; 33(12 Suppl):S468-S471
29. Okubo N, Hatori N, Ochi M, et al: Comparison of m-RNA expression for inflammatory mediators in leukocytes between on-pump and off-pump coronary artery bypass grafting. Ann Thorac Cardiovasc Surg 2003; 9:43-49
30. Wan S, DeSmet JM, Barvais L, et al: Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996; 112:806-811
31. Shames BD, Barton HH, Reznikov LL, et al: Ischemia alone is sufficient to induce TNF-alpha mRNA and peptide in the myocardium. Shock 2002; 17:114-119
32. Eskdale J, Gallagher G, Verweij CL, et al: Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A 1998; 95:9465-9470
33. Lowe PR, Galley HF, Abdel-Fattah A, et al: Influence of interleukin-10 polymorphism on interleukin-10 expression and survival in critically ill patients. Crit Care Med 2003; 31:34-38